You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

VENLAFAXINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Venlafaxine Hydrochloride, and what generic alternatives are available?

Venlafaxine Hydrochloride is a drug marketed by Alembic, Anchen Pharms, Annora Pharma, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Granules, Intellipharmaceutics, Inventia Hlthcare, Macleods Pharms Ltd, Norvium Bioscience, Nostrum Pharms Llc, Orbion Pharms, Teva, Torrent, Valeant Pharms North, Wockhardt Bio Ag, Yichang Humanwell, Zydus Pharms Usa Inc, Ajanta Pharma Ltd, Alkem Labs Ltd, Appco, Ascent Pharms Inc, Cadila Pharms Ltd, Dexcel, Nostrum Labs Inc, Osmotica Pharm Us, Sun Pharm, Swiss Pharm, Unique, Zydus Pharms, Alembic Pharms Ltd, Amneal Pharms, Aurobindo Pharma, Chartwell Rx, Heritage Pharms, Mylan, Pliva Hrvatska Doo, Prinston Inc, Sun Pharm Inds Inc, Yaopharma Co Ltd, and Zydus Pharms Usa. and is included in forty-five NDAs.

The generic ingredient in VENLAFAXINE HYDROCHLORIDE is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Venlafaxine Hydrochloride

A generic version of VENLAFAXINE HYDROCHLORIDE was approved as venlafaxine hydrochloride by TEVA on August 3rd, 2006.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VENLAFAXINE HYDROCHLORIDE?
  • What are the global sales for VENLAFAXINE HYDROCHLORIDE?
  • What is Average Wholesale Price for VENLAFAXINE HYDROCHLORIDE?
Drug patent expirations by year for VENLAFAXINE HYDROCHLORIDE
Recent Clinical Trials for VENLAFAXINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Reinier de Graaf GroepPhase 3
Shalamar Institute of Health SciencesN/A
Westfälische Wilhelms-Universität MünsterPhase 4

See all VENLAFAXINE HYDROCHLORIDE clinical trials

Pharmacology for VENLAFAXINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for VENLAFAXINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for VENLAFAXINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for VENLAFAXINE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VENLAFAXINE HYDROCHLORIDE Extended-release Tablets venlafaxine hydrochloride 225 mg 022104 1 2011-01-10
VENLAFAXINE HYDROCHLORIDE Extended-release Tablets venlafaxine hydrochloride 37.5 mg, 75 mg and 150 mg 022104 1 2009-02-12
EFFEXOR XR Extended-release Tablets venlafaxine hydrochloride 37.5 mg, 75 mg and 150 mg 020699 1 2007-05-03
EFFEXOR Tablets venlafaxine hydrochloride 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg 020151 1 2005-11-03

US Patents and Regulatory Information for VENLAFAXINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dexcel VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 213927-001 Jan 21, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 079098-002 May 11, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Torrent VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 090899-002 Jun 1, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Nostrum Pharms Llc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 200430-002 Apr 4, 2023 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Yaopharma Co Ltd VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 202036-004 May 28, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VENLAFAXINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-002 May 20, 2008 ⤷  Sign Up ⤷  Sign Up
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-001 May 20, 2008 ⤷  Sign Up ⤷  Sign Up
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-004 May 20, 2008 ⤷  Sign Up ⤷  Sign Up
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-002 May 20, 2008 ⤷  Sign Up ⤷  Sign Up
Osmotica Pharm Us VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-003 May 20, 2008 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for VENLAFAXINE HYDROCHLORIDE

See the table below for patents covering VENLAFAXINE HYDROCHLORIDE around the world.

Country Patent Number Title Estimated Expiration
El Salvador 1998000131 FORMULACIONES DE ACCION PROLONGADA REF. AHP-95011-1-C1 ⤷  Sign Up
India 187337 A process for preparing an encapsulated extended release formulation of venlafaxine hydrochloride ⤷  Sign Up
Norway 971206 ⤷  Sign Up
Japan H107552 SUSTAINED RELEASE PHARMACEUTICAL PREPARATION ⤷  Sign Up
China 1278165 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.